

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 6.19105432 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.19105432 |
| 3 | COPII vesicle coating (GO:0048208) | 4.71630416 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.48697991 |
| 5 | growth hormone receptor signaling pathway (GO:0060396) | 4.12238278 |
| 6 | protein retention in ER lumen (GO:0006621) | 4.04135146 |
| 7 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.99387323 |
| 8 | positive regulation of nuclease activity (GO:0032075) | 3.85142345 |
| 9 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.56118823 |
| 10 | cellular response to growth hormone stimulus (GO:0071378) | 3.55676330 |
| 11 | regulation of nuclease activity (GO:0032069) | 3.51227074 |
| 12 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.47519865 |
| 13 | cellular response to unfolded protein (GO:0034620) | 3.44867989 |
| 14 | ER-nucleus signaling pathway (GO:0006984) | 3.34418689 |
| 15 | vesicle coating (GO:0006901) | 3.29714323 |
| 16 | cellular response to topologically incorrect protein (GO:0035967) | 3.26924794 |
| 17 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.26074364 |
| 18 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.24778855 |
| 19 | type B pancreatic cell development (GO:0003323) | 3.21802200 |
| 20 | positive regulation of p38MAPK cascade (GO:1900745) | 3.21434553 |
| 21 | 4-hydroxyproline metabolic process (GO:0019471) | 3.20775914 |
| 22 | negative regulation of fatty acid transport (GO:2000192) | 3.17531954 |
| 23 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.13086305 |
| 24 | exocrine pancreas development (GO:0031017) | 3.10814303 |
| 25 | basement membrane organization (GO:0071711) | 3.10242847 |
| 26 | response to laminar fluid shear stress (GO:0034616) | 2.99552317 |
| 27 | urea cycle (GO:0000050) | 2.97640085 |
| 28 | pinocytosis (GO:0006907) | 2.95340784 |
| 29 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.95068105 |
| 30 | intestinal absorption (GO:0050892) | 2.91173946 |
| 31 | intestinal epithelial cell development (GO:0060576) | 2.88198528 |
| 32 | urea metabolic process (GO:0019627) | 2.86874702 |
| 33 | glandular epithelial cell development (GO:0002068) | 2.83718849 |
| 34 | response to endoplasmic reticulum stress (GO:0034976) | 2.83457743 |
| 35 | positive regulation of extracellular matrix organization (GO:1903055) | 2.82490146 |
| 36 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.81095350 |
| 37 | valine metabolic process (GO:0006573) | 2.78852230 |
| 38 | hormone catabolic process (GO:0042447) | 2.77497155 |
| 39 | intestinal cholesterol absorption (GO:0030299) | 2.77115763 |
| 40 | hepatocyte apoptotic process (GO:0097284) | 2.77056638 |
| 41 | positive regulation of histone deacetylation (GO:0031065) | 2.75871680 |
| 42 | desmosome organization (GO:0002934) | 2.75438434 |
| 43 | cellular response to vitamin D (GO:0071305) | 2.75309279 |
| 44 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.74984481 |
| 45 | focal adhesion assembly (GO:0048041) | 2.74210468 |
| 46 | cell-substrate adherens junction assembly (GO:0007045) | 2.74210468 |
| 47 | definitive hemopoiesis (GO:0060216) | 2.74171075 |
| 48 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.73686397 |
| 49 | surfactant homeostasis (GO:0043129) | 2.72744100 |
| 50 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.72264393 |
| 51 | adherens junction assembly (GO:0034333) | 2.69655073 |
| 52 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.69600684 |
| 53 | corticosteroid receptor signaling pathway (GO:0031958) | 2.69285874 |
| 54 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.67174844 |
| 55 | apoptotic cell clearance (GO:0043277) | 2.65406481 |
| 56 | pentose-phosphate shunt (GO:0006098) | 2.63798951 |
| 57 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.63477670 |
| 58 | regulation of early endosome to late endosome transport (GO:2000641) | 2.62500785 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 2.62144291 |
| 60 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.61942785 |
| 61 | protein localization to endosome (GO:0036010) | 2.61455373 |
| 62 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.60438529 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.59773540 |
| 64 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.59604954 |
| 65 | epithelial cell-cell adhesion (GO:0090136) | 2.58620657 |
| 66 | response to unfolded protein (GO:0006986) | 2.57615857 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.57499204 |
| 68 | cell adhesion mediated by integrin (GO:0033627) | 2.57005210 |
| 69 | regulation of protein activation cascade (GO:2000257) | 2.56730432 |
| 70 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.55606577 |
| 71 | negative regulation of lipid transport (GO:0032369) | 2.55507085 |
| 72 | maternal placenta development (GO:0001893) | 2.54500104 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 2.54101014 |
| 74 | trophectodermal cell differentiation (GO:0001829) | 2.53919139 |
| 75 | sequestering of metal ion (GO:0051238) | 2.52924846 |
| 76 | regulation of complement activation (GO:0030449) | 2.52770933 |
| 77 | response to topologically incorrect protein (GO:0035966) | 2.48723204 |
| 78 | proline biosynthetic process (GO:0006561) | 2.48228410 |
| 79 | hemidesmosome assembly (GO:0031581) | 2.48159707 |
| 80 | endocrine pancreas development (GO:0031018) | 2.47677064 |
| 81 | hypotonic response (GO:0006971) | 2.46035313 |
| 82 | cellular protein complex localization (GO:0034629) | 2.45588546 |
| 83 | * Golgi organization (GO:0007030) | 2.44542855 |
| 84 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.44454263 |
| 85 | sulfur amino acid catabolic process (GO:0000098) | 2.42890892 |
| 86 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.41971384 |
| 87 | histone H2A monoubiquitination (GO:0035518) | 2.41545077 |
| 88 | regulation of RNA export from nucleus (GO:0046831) | 2.41313525 |
| 89 | macroautophagy (GO:0016236) | 2.41090972 |
| 90 | lysine metabolic process (GO:0006553) | 2.40703360 |
| 91 | lysine catabolic process (GO:0006554) | 2.40703360 |
| 92 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.40152274 |
| 93 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.39179856 |
| 94 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.38616981 |
| 95 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.38616981 |
| 96 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.38170644 |
| 97 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.36980926 |
| 98 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.36763353 |
| 99 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.36577643 |
| 100 | stress fiber assembly (GO:0043149) | 2.36238960 |
| 101 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.35602372 |
| 102 | cysteine metabolic process (GO:0006534) | 2.35556647 |
| 103 | cellular response to vitamin (GO:0071295) | 2.34829173 |
| 104 | nuclear pore organization (GO:0006999) | 2.34461470 |
| 105 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.33256625 |
| 106 | negative regulation of protein activation cascade (GO:2000258) | 2.32760349 |
| 107 | protein carboxylation (GO:0018214) | 2.32503140 |
| 108 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.32503140 |
| 109 | NADPH regeneration (GO:0006740) | 2.31816514 |
| 110 | cell-substrate junction assembly (GO:0007044) | 2.31212103 |
| 111 | transcytosis (GO:0045056) | 2.30851145 |
| 112 | RNA stabilization (GO:0043489) | 2.30418344 |
| 113 | mRNA stabilization (GO:0048255) | 2.30418344 |
| 114 | alpha-linolenic acid metabolic process (GO:0036109) | 2.29747645 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 2.29626928 |
| 116 | tricarboxylic acid metabolic process (GO:0072350) | 2.28810402 |
| 117 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.28746059 |
| 118 | peptidyl-proline hydroxylation (GO:0019511) | 2.28626979 |
| 119 | embryonic process involved in female pregnancy (GO:0060136) | 2.28044976 |
| 120 | endothelium development (GO:0003158) | 2.26536325 |
| 121 | gland morphogenesis (GO:0022612) | 2.26148732 |
| 122 | DNA unwinding involved in DNA replication (GO:0006268) | 2.25151608 |
| 123 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.24957117 |
| 124 | purine ribonucleotide transport (GO:0015868) | 2.24902147 |
| 125 | keratan sulfate catabolic process (GO:0042340) | 2.24817391 |
| 126 | protein complex localization (GO:0031503) | 2.24600702 |
| 127 | negative regulation of fibrinolysis (GO:0051918) | 2.22624106 |
| 128 | regulation of hippo signaling (GO:0035330) | 2.21002810 |
| 129 | complement activation, alternative pathway (GO:0006957) | 2.18962490 |
| 130 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.18056344 |
| 131 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.18032547 |
| 132 | mitotic chromosome condensation (GO:0007076) | 2.17618432 |
| 133 | membrane raft organization (GO:0031579) | 2.17468044 |
| 134 | protein hydroxylation (GO:0018126) | 2.17325044 |
| 135 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.17251612 |
| 136 | hyaluronan catabolic process (GO:0030214) | 2.16750349 |
| 137 | embryonic foregut morphogenesis (GO:0048617) | 2.16731259 |
| 138 | regulation of transforming growth factor beta production (GO:0071634) | 2.15569216 |
| 139 | response to growth hormone (GO:0060416) | 2.15560175 |
| 140 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.15445270 |
| 141 | ER overload response (GO:0006983) | 2.14879292 |
| 142 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.14627070 |
| 143 | negative regulation of complement activation (GO:0045916) | 2.14585427 |
| 144 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.14479571 |
| 145 | membrane protein ectodomain proteolysis (GO:0006509) | 2.14262792 |
| 146 | cellular hyperosmotic response (GO:0071474) | 2.13718476 |
| 147 | response to thyroid hormone (GO:0097066) | 2.13386473 |
| 148 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.13276816 |
| 149 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.12321104 |
| 150 | regulation of metalloenzyme activity (GO:0048552) | 2.12081808 |
| 151 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.12061889 |
| 152 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.10988797 |
| 153 | regulation of extracellular matrix organization (GO:1903053) | 2.10889736 |
| 154 | purine nucleotide transport (GO:0015865) | 2.10840830 |
| 155 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.10274309 |
| 156 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.09855730 |
| 157 | homocysteine metabolic process (GO:0050667) | 2.09659638 |
| 158 | iron ion import (GO:0097286) | 2.09536732 |
| 159 | nuclear pore complex assembly (GO:0051292) | 2.09167693 |
| 160 | skin morphogenesis (GO:0043589) | 2.08607555 |
| 161 | regulation of histone H3-K27 methylation (GO:0061085) | 2.08521188 |
| 162 | positive regulation of glycolytic process (GO:0045821) | 2.08455238 |
| 163 | intracellular lipid transport (GO:0032365) | 2.08307434 |
| 164 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.08071156 |
| 165 | protein autoprocessing (GO:0016540) | 2.07968674 |
| 166 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.07393019 |
| 167 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.06554902 |
| 168 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.05889035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.31047301 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.58803059 |
| 3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.50178306 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.45460409 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.43727959 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.25981004 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.22781996 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.02466368 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.75279609 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68300998 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47904858 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46943013 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31408211 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12407150 |
| 15 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.12334271 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.01103013 |
| 17 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.91389739 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89847719 |
| 19 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.89573402 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.85653702 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84109550 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82302452 |
| 23 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.78484010 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76914936 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76706924 |
| 26 | ATF3_27146783_Chip-Seq_COLON_Human | 1.68664153 |
| 27 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.67704365 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67588238 |
| 29 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.67523124 |
| 30 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.66405282 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.65764248 |
| 32 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.64668227 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.64196394 |
| 34 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64114151 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62575686 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.62113287 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60264407 |
| 38 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.59762869 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59640056 |
| 40 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.59620118 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.58700358 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58375313 |
| 43 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.56768254 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.56581127 |
| 45 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.55440423 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51511221 |
| 47 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.51282107 |
| 48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50263809 |
| 49 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.49724971 |
| 50 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.47881337 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47350837 |
| 52 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47136662 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45435959 |
| 54 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44518655 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43714776 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43578756 |
| 57 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39799471 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38483920 |
| 59 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.38014377 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36620288 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36551121 |
| 62 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.33285123 |
| 63 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32533285 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31816695 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31321626 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.31316492 |
| 67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31045733 |
| 68 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27787166 |
| 69 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.26848621 |
| 70 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26480895 |
| 71 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.26480895 |
| 72 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.26243825 |
| 73 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24632819 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24510470 |
| 75 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.23586505 |
| 76 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.23470630 |
| 77 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.23258191 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23168731 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22226529 |
| 80 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22107468 |
| 81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21462938 |
| 82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21348075 |
| 83 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.20934366 |
| 84 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.20270336 |
| 85 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20087934 |
| 86 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19921465 |
| 87 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.19464990 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19431077 |
| 89 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19172582 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18022304 |
| 91 | MYB_26560356_Chip-Seq_TH2_Human | 1.17832850 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17637771 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17271609 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16693592 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16645492 |
| 96 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16463914 |
| 97 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16255419 |
| 98 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16190513 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15763003 |
| 100 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.14772139 |
| 101 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.14772139 |
| 102 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.14772139 |
| 103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14121504 |
| 104 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13691786 |
| 105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12913997 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12385995 |
| 107 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12273176 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10767657 |
| 109 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10315637 |
| 110 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09932956 |
| 111 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08230090 |
| 112 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08100835 |
| 113 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.07497752 |
| 114 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07147212 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07027414 |
| 116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06653676 |
| 117 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.06309510 |
| 118 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.06136407 |
| 119 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05444640 |
| 120 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05282104 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05229208 |
| 122 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05171191 |
| 123 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04964687 |
| 124 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04759788 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04403926 |
| 126 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03873496 |
| 127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.03835715 |
| 128 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03089016 |
| 129 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.02671644 |
| 130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02102614 |
| 131 | MYB_26560356_Chip-Seq_TH1_Human | 0.99084213 |
| 132 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98898304 |
| 133 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98348038 |
| 134 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98273819 |
| 135 | MAF_26560356_Chip-Seq_TH1_Human | 0.97323287 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97059722 |
| 137 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96509022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.91933642 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.55110764 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.45931760 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.25195792 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.76618506 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.57104264 |
| 7 | MP0006054_spinal_hemorrhage | 2.50920089 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.32453700 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.32359124 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 2.25910627 |
| 11 | MP0005451_abnormal_body_composition | 2.25069493 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.05234187 |
| 13 | MP0002796_impaired_skin_barrier | 2.00685329 |
| 14 | MP0003252_abnormal_bile_duct | 1.92262426 |
| 15 | MP0005365_abnormal_bile_salt | 1.88671295 |
| 16 | MP0005360_urolithiasis | 1.80967694 |
| 17 | MP0003566_abnormal_cell_adhesion | 1.74488125 |
| 18 | MP0001666_abnormal_nutrient_absorption | 1.72475106 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 1.67849364 |
| 20 | MP0005220_abnormal_exocrine_pancreas | 1.61510297 |
| 21 | MP0009384_cardiac_valve_regurgitation | 1.57294480 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.57123116 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.50055411 |
| 24 | MP0001849_ear_inflammation | 1.48928035 |
| 25 | MP0002896_abnormal_bone_mineralization | 1.48242090 |
| 26 | MP0005623_abnormal_meninges_morphology | 1.45101349 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 1.40713012 |
| 28 | MP0005501_abnormal_skin_physiology | 1.39243867 |
| 29 | MP0001944_abnormal_pancreas_morphology | 1.38561613 |
| 30 | MP0001881_abnormal_mammary_gland | 1.38117267 |
| 31 | MP0003195_calcinosis | 1.36834430 |
| 32 | MP0005275_abnormal_skin_tensile | 1.36782035 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.27496279 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.27114575 |
| 35 | MP0005023_abnormal_wound_healing | 1.26446414 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.26401902 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.23521283 |
| 38 | MP0009278_abnormal_bone_marrow | 1.22681800 |
| 39 | MP0010307_abnormal_tumor_latency | 1.22532318 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.18259038 |
| 41 | MP0002060_abnormal_skin_morphology | 1.18210981 |
| 42 | MP0002009_preneoplasia | 1.15781198 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.15740635 |
| 44 | MP0002254_reproductive_system_inflammat | 1.15506788 |
| 45 | MP0003045_fibrosis | 1.15361537 |
| 46 | MP0002693_abnormal_pancreas_physiology | 1.14188473 |
| 47 | MP0000609_abnormal_liver_physiology | 1.12972633 |
| 48 | MP0001730_embryonic_growth_arrest | 1.12596761 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.12354398 |
| 50 | MP0004947_skin_inflammation | 1.11178098 |
| 51 | MP0003303_peritoneal_inflammation | 1.10597609 |
| 52 | MP0005409_darkened_coat_color | 1.10218145 |
| 53 | MP0003279_aneurysm | 1.09540256 |
| 54 | MP0002928_abnormal_bile_duct | 1.07599729 |
| 55 | MP0005083_abnormal_biliary_tract | 1.07295464 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.07234785 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.06002477 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.05957696 |
| 59 | MP0003941_abnormal_skin_development | 1.05811532 |
| 60 | MP0002006_tumorigenesis | 1.05458523 |
| 61 | MP0003283_abnormal_digestive_organ | 1.05140084 |
| 62 | MP0002168_other_aberrant_phenotype | 1.04613453 |
| 63 | MP0010678_abnormal_skin_adnexa | 1.03824249 |
| 64 | MP0008004_abnormal_stomach_pH | 1.03675178 |
| 65 | MP0003436_decreased_susceptibility_to | 1.01349370 |
| 66 | MP0004272_abnormal_basement_membrane | 1.00895853 |
| 67 | MP0003868_abnormal_feces_composition | 0.99462566 |
| 68 | MP0005464_abnormal_platelet_physiology | 0.98965794 |
| 69 | MP0000003_abnormal_adipose_tissue | 0.98506160 |
| 70 | MP0005248_abnormal_Harderian_gland | 0.98320358 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.96956136 |
| 72 | MP0003091_abnormal_cell_migration | 0.96945607 |
| 73 | MP0003795_abnormal_bone_structure | 0.96904390 |
| 74 | MP0008260_abnormal_autophagy | 0.96281519 |
| 75 | MP0005621_abnormal_cell_physiology | 0.95778686 |
| 76 | MP0010329_abnormal_lipoprotein_level | 0.94992195 |
| 77 | MP0000767_abnormal_smooth_muscle | 0.94556392 |
| 78 | MP0000350_abnormal_cell_proliferation | 0.93486471 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.91963980 |
| 80 | MP0004957_abnormal_blastocyst_morpholog | 0.91911695 |
| 81 | MP0000858_altered_metastatic_potential | 0.90801742 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.90444730 |
| 83 | MP0003828_pulmonary_edema | 0.90277364 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.90025288 |
| 85 | MP0003950_abnormal_plasma_membrane | 0.89222212 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.88731541 |
| 87 | MP0003984_embryonic_growth_retardation | 0.87430669 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.86414515 |
| 89 | MP0000462_abnormal_digestive_system | 0.86376738 |
| 90 | MP0000733_abnormal_muscle_development | 0.86349610 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.85248463 |
| 92 | MP0010630_abnormal_cardiac_muscle | 0.84556522 |
| 93 | MP0001915_intracranial_hemorrhage | 0.84220678 |
| 94 | MP0005165_increased_susceptibility_to | 0.83204991 |
| 95 | MP0009840_abnormal_foam_cell | 0.81974782 |
| 96 | MP0001851_eye_inflammation | 0.81973430 |
| 97 | MP0009053_abnormal_anal_canal | 0.81843816 |
| 98 | MP0000627_abnormal_mammary_gland | 0.81186409 |
| 99 | MP0002086_abnormal_extraembryonic_tissu | 0.79748187 |
| 100 | MP0005380_embryogenesis_phenotype | 0.79577943 |
| 101 | MP0001672_abnormal_embryogenesis/_devel | 0.79577943 |
| 102 | MP0005503_abnormal_tendon_morphology | 0.78868656 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.78326660 |
| 104 | MP0000163_abnormal_cartilage_morphology | 0.77473711 |
| 105 | MP0000537_abnormal_urethra_morphology | 0.76395292 |
| 106 | MP0001958_emphysema | 0.75712809 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.75507382 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75307741 |
| 109 | MP0000598_abnormal_liver_morphology | 0.75049358 |
| 110 | MP0002098_abnormal_vibrissa_morphology | 0.75024291 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.74834903 |
| 112 | MP0005408_hypopigmentation | 0.74681420 |
| 113 | MP0004233_abnormal_muscle_weight | 0.74654888 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.74610322 |
| 115 | MP0001853_heart_inflammation | 0.74493532 |
| 116 | MP0002080_prenatal_lethality | 0.74481392 |
| 117 | MP0005397_hematopoietic_system_phenotyp | 0.74040266 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.74040266 |
| 119 | MP0004858_abnormal_nervous_system | 0.73571001 |
| 120 | MP0003448_altered_tumor_morphology | 0.73326091 |
| 121 | MP0003763_abnormal_thymus_physiology | 0.73108915 |
| 122 | MP0009333_abnormal_splenocyte_physiolog | 0.73063081 |
| 123 | MP0005508_abnormal_skeleton_morphology | 0.72976017 |
| 124 | MP0005390_skeleton_phenotype | 0.72867586 |
| 125 | MP0000377_abnormal_hair_follicle | 0.72825089 |
| 126 | MP0000613_abnormal_salivary_gland | 0.72764326 |
| 127 | MP0000490_abnormal_crypts_of | 0.71810880 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.71654575 |
| 129 | MP0009931_abnormal_skin_appearance | 0.71480466 |
| 130 | MP0002115_abnormal_skeleton_extremities | 0.70975252 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70910477 |
| 132 | MP0002113_abnormal_skeleton_development | 0.67994551 |
| 133 | MP0001216_abnormal_epidermal_layer | 0.67356516 |
| 134 | MP0005257_abnormal_intraocular_pressure | 0.66247703 |
| 135 | MP0002933_joint_inflammation | 0.65425302 |
| 136 | MP0000477_abnormal_intestine_morphology | 0.65208172 |
| 137 | MP0003806_abnormal_nucleotide_metabolis | 0.63876450 |
| 138 | MP0004197_abnormal_fetal_growth/weight/ | 0.63783468 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.63612450 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.63313886 |
| 141 | MP0002088_abnormal_embryonic_growth/wei | 0.62032130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 3.19829843 |
| 2 | Subacute progressive viral hepatitis (HP:0006572) | 3.07936413 |
| 3 | Cervical subluxation (HP:0003308) | 3.05477374 |
| 4 | Hyperglycemia (HP:0003074) | 3.01594111 |
| 5 | Vertebral compression fractures (HP:0002953) | 2.94222353 |
| 6 | Ankle contracture (HP:0006466) | 2.79526884 |
| 7 | Protrusio acetabuli (HP:0003179) | 2.71768769 |
| 8 | Hypoglycemic seizures (HP:0002173) | 2.69534027 |
| 9 | Abnormality of the intrinsic pathway (HP:0010989) | 2.66079348 |
| 10 | Asymmetry of the thorax (HP:0001555) | 2.65031611 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.62486838 |
| 12 | Hematochezia (HP:0002573) | 2.57588269 |
| 13 | Myocardial infarction (HP:0001658) | 2.57459005 |
| 14 | Mucopolysacchariduria (HP:0008155) | 2.57397534 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.57397534 |
| 16 | Spinal cord lesions (HP:0100561) | 2.51210189 |
| 17 | Syringomyelia (HP:0003396) | 2.51210189 |
| 18 | Metaphyseal cupping (HP:0003021) | 2.42756930 |
| 19 | Epiphyseal dysplasia (HP:0002656) | 2.39999760 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 2.39606248 |
| 21 | Spondylolisthesis (HP:0003302) | 2.38228924 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37497547 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37497547 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37497547 |
| 25 | Exostoses (HP:0100777) | 2.36975422 |
| 26 | Thoracolumbar scoliosis (HP:0002944) | 2.36009436 |
| 27 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.34746983 |
| 28 | Papillary thyroid carcinoma (HP:0002895) | 2.30347587 |
| 29 | Abnormality of complement system (HP:0005339) | 2.29231814 |
| 30 | Flat acetabular roof (HP:0003180) | 2.28910428 |
| 31 | Rectal prolapse (HP:0002035) | 2.28023537 |
| 32 | Polycythemia (HP:0001901) | 2.25730847 |
| 33 | Deep venous thrombosis (HP:0002625) | 2.24738949 |
| 34 | Aneurysm (HP:0002617) | 2.24363846 |
| 35 | Wormian bones (HP:0002645) | 2.24287557 |
| 36 | Mitral valve prolapse (HP:0001634) | 2.21114978 |
| 37 | Esophageal varix (HP:0002040) | 2.20392495 |
| 38 | Sparse lateral eyebrow (HP:0005338) | 2.19728611 |
| 39 | Enlarged penis (HP:0000040) | 2.19053197 |
| 40 | Ketoacidosis (HP:0001993) | 2.18665323 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.18069465 |
| 42 | Aortic aneurysm (HP:0004942) | 2.17231748 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.17098083 |
| 44 | Complement deficiency (HP:0004431) | 2.16755253 |
| 45 | Abnormal foot bone ossification (HP:0010675) | 2.16443123 |
| 46 | Micronodular cirrhosis (HP:0001413) | 2.12650504 |
| 47 | Gout (HP:0001997) | 2.12582390 |
| 48 | Cupped ribs (HP:0000887) | 2.10764876 |
| 49 | Ankyloglossia (HP:0010296) | 2.10547131 |
| 50 | Cortical dysplasia (HP:0002539) | 2.09617998 |
| 51 | Abnormality of the Achilles tendon (HP:0005109) | 2.09122132 |
| 52 | Atrophic scars (HP:0001075) | 2.09068633 |
| 53 | Late onset (HP:0003584) | 2.08760978 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.07421344 |
| 55 | Achilles tendon contracture (HP:0001771) | 2.06897432 |
| 56 | Short nail (HP:0001799) | 2.06354868 |
| 57 | Osteolytic defects of the hand bones (HP:0009699) | 2.05819913 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05819913 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.05222422 |
| 60 | Hyperacusis (HP:0010780) | 2.04977181 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.04597983 |
| 62 | Peritonitis (HP:0002586) | 2.04114253 |
| 63 | Thin bony cortex (HP:0002753) | 2.02616396 |
| 64 | Intrahepatic cholestasis (HP:0001406) | 2.01661214 |
| 65 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.01567551 |
| 66 | Hypoplastic ischia (HP:0003175) | 2.00317279 |
| 67 | Back pain (HP:0003418) | 1.99323704 |
| 68 | Cerebral aneurysm (HP:0004944) | 1.99244342 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.99186696 |
| 70 | Abnormality of carpal bone ossification (HP:0006257) | 1.98986180 |
| 71 | Hydroxyprolinuria (HP:0003080) | 1.98836352 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 1.98836352 |
| 73 | Symptomatic seizures (HP:0011145) | 1.97036853 |
| 74 | Blue sclerae (HP:0000592) | 1.96309209 |
| 75 | Mitral stenosis (HP:0001718) | 1.95763689 |
| 76 | Macroorchidism (HP:0000053) | 1.94934209 |
| 77 | Aortic dissection (HP:0002647) | 1.94578102 |
| 78 | Abnormal pancreas size (HP:0012094) | 1.94327553 |
| 79 | Abnormality of the ischium (HP:0003174) | 1.93961066 |
| 80 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.93749265 |
| 81 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.93749265 |
| 82 | Abnormality of oral frenula (HP:0000190) | 1.92149247 |
| 83 | Abnormal delivery (HP:0001787) | 1.90273615 |
| 84 | Genu recurvatum (HP:0002816) | 1.89310238 |
| 85 | Abnormal ossification of hand bones (HP:0005921) | 1.89154366 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 1.87913034 |
| 87 | Protuberant abdomen (HP:0001538) | 1.87211751 |
| 88 | Right ventricular cardiomyopathy (HP:0011663) | 1.87211109 |
| 89 | Fragile skin (HP:0001030) | 1.86376506 |
| 90 | Shallow orbits (HP:0000586) | 1.86156177 |
| 91 | Long toe (HP:0010511) | 1.85852863 |
| 92 | Increased CSF protein (HP:0002922) | 1.85105373 |
| 93 | Distal lower limb muscle weakness (HP:0009053) | 1.84314207 |
| 94 | Insulin resistance (HP:0000855) | 1.84307004 |
| 95 | Growth hormone excess (HP:0000845) | 1.83550361 |
| 96 | Severe short stature (HP:0003510) | 1.82801575 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 1.82243887 |
| 98 | Abnormal tarsal ossification (HP:0008369) | 1.82061961 |
| 99 | Exocrine pancreatic insufficiency (HP:0001738) | 1.81551203 |
| 100 | Tetraparesis (HP:0002273) | 1.81152306 |
| 101 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80853054 |
| 102 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.80730664 |
| 103 | Persistence of primary teeth (HP:0006335) | 1.80185555 |
| 104 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.80038806 |
| 105 | Ulnar bowing (HP:0003031) | 1.79785248 |
| 106 | Xanthomatosis (HP:0000991) | 1.79101407 |
| 107 | Abdominal distention (HP:0003270) | 1.77270296 |
| 108 | Hyperparathyroidism (HP:0000843) | 1.77183982 |
| 109 | Abnormal biliary tract morphology (HP:0012440) | 1.76149726 |
| 110 | Premature rupture of membranes (HP:0001788) | 1.75625230 |
| 111 | Arterial tortuosity (HP:0005116) | 1.75363973 |
| 112 | Milia (HP:0001056) | 1.74745223 |
| 113 | Cellulitis (HP:0100658) | 1.74517784 |
| 114 | Dilatation of the ascending aorta (HP:0005111) | 1.74406316 |
| 115 | Advanced eruption of teeth (HP:0006288) | 1.71090957 |
| 116 | Broad face (HP:0000283) | 1.69695168 |
| 117 | Biliary tract neoplasm (HP:0100574) | 1.68866547 |
| 118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.68607621 |
| 119 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.68517426 |
| 120 | Ketosis (HP:0001946) | 1.68042776 |
| 121 | Abnormality of the fingertips (HP:0001211) | 1.67217087 |
| 122 | Spastic diplegia (HP:0001264) | 1.67123368 |
| 123 | Vertebral arch anomaly (HP:0008438) | 1.66380520 |
| 124 | Systemic lupus erythematosus (HP:0002725) | 1.65763362 |
| 125 | Hyperextensible skin (HP:0000974) | 1.65570377 |
| 126 | Elbow flexion contracture (HP:0002987) | 1.65558780 |
| 127 | Bladder diverticulum (HP:0000015) | 1.65505100 |
| 128 | Abnormality of the gastric mucosa (HP:0004295) | 1.65499469 |
| 129 | Gastrointestinal infarctions (HP:0005244) | 1.64070641 |
| 130 | Bone pain (HP:0002653) | 1.64024505 |
| 131 | Hypercholesterolemia (HP:0003124) | 1.63137318 |
| 132 | Striae distensae (HP:0001065) | 1.62947031 |
| 133 | Vascular tortuosity (HP:0004948) | 1.62789981 |
| 134 | Platyspondyly (HP:0000926) | 1.62684326 |
| 135 | Glomerulonephritis (HP:0000099) | 1.61853208 |
| 136 | Distal lower limb amyotrophy (HP:0008944) | 1.61785256 |
| 137 | Orthostatic hypotension (HP:0001278) | 1.61305860 |
| 138 | Delayed cranial suture closure (HP:0000270) | 1.60644302 |
| 139 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.60506598 |
| 140 | Fatigue (HP:0012378) | 1.59595827 |
| 141 | Joint laxity (HP:0001388) | 1.59285043 |
| 142 | Camptodactyly of toe (HP:0001836) | 1.59043935 |
| 143 | Thyroid carcinoma (HP:0002890) | 1.58839488 |
| 144 | Abnormality of the acetabulum (HP:0003170) | 1.58674547 |
| 145 | Cardiovascular calcification (HP:0011915) | 1.58445590 |
| 146 | Broad metatarsal (HP:0001783) | 1.58332505 |
| 147 | Deep philtrum (HP:0002002) | 1.57219179 |
| 148 | Abnormality of Sharpey fibers (HP:0100685) | 1.56921803 |
| 149 | Chondrocalcinosis (HP:0000934) | 1.56854287 |
| 150 | Breech presentation (HP:0001623) | 1.55754087 |
| 151 | Biconcave vertebral bodies (HP:0004586) | 1.55391556 |
| 152 | Elevated alkaline phosphatase (HP:0003155) | 1.55353302 |
| 153 | Polygenic inheritance (HP:0010982) | 1.54933621 |
| 154 | Absent frontal sinuses (HP:0002688) | 1.54377286 |
| 155 | Nonimmune hydrops fetalis (HP:0001790) | 1.53534170 |
| 156 | Stroke (HP:0001297) | 1.53066303 |
| 157 | Abnormality of the thoracic spine (HP:0100711) | 1.52739853 |
| 158 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.52593824 |
| 159 | Termporal pattern (HP:0011008) | 1.52581727 |
| 160 | Insidious onset (HP:0003587) | 1.52581727 |
| 161 | Eczematoid dermatitis (HP:0000976) | 1.52483089 |
| 162 | Abnormality of the lumbar spine (HP:0100712) | 1.52087353 |
| 163 | Coarse hair (HP:0002208) | 1.50222865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.24758050 |
| 2 | LATS1 | 4.10477595 |
| 3 | SMG1 | 2.78906358 |
| 4 | PKN2 | 2.77565824 |
| 5 | ERN1 | 2.74492976 |
| 6 | FRK | 2.73881439 |
| 7 | PRPF4B | 2.47684006 |
| 8 | TAOK3 | 2.44868866 |
| 9 | EEF2K | 2.05489146 |
| 10 | STK3 | 2.05054768 |
| 11 | IRAK3 | 2.04772559 |
| 12 | PTK6 | 1.97638074 |
| 13 | TESK1 | 1.96129275 |
| 14 | MAP3K2 | 1.92007058 |
| 15 | SIK1 | 1.67362441 |
| 16 | LRRK2 | 1.64056096 |
| 17 | MAP3K3 | 1.59501315 |
| 18 | EPHA3 | 1.59218677 |
| 19 | STK10 | 1.59006047 |
| 20 | SCYL2 | 1.51740922 |
| 21 | NEK9 | 1.51638267 |
| 22 | RIPK1 | 1.51445497 |
| 23 | FGFR3 | 1.48105346 |
| 24 | ICK | 1.47585537 |
| 25 | ERBB4 | 1.46399447 |
| 26 | JAK3 | 1.45372024 |
| 27 | STK38L | 1.45185281 |
| 28 | PRKD3 | 1.43894279 |
| 29 | CDK6 | 1.43109471 |
| 30 | FGFR4 | 1.42209619 |
| 31 | PDGFRA | 1.41405091 |
| 32 | FLT3 | 1.40725398 |
| 33 | RPS6KA4 | 1.39584383 |
| 34 | EPHB1 | 1.31780497 |
| 35 | HIPK2 | 1.24247112 |
| 36 | JAK1 | 1.24022293 |
| 37 | RET | 1.22958116 |
| 38 | PTK2 | 1.20452616 |
| 39 | TESK2 | 1.20257685 |
| 40 | MAP3K10 | 1.18859092 |
| 41 | NLK | 1.18647590 |
| 42 | LATS2 | 1.18271966 |
| 43 | MAP3K13 | 1.17564716 |
| 44 | KSR2 | 1.16561103 |
| 45 | CDK12 | 1.15547996 |
| 46 | MAP2K3 | 1.15390084 |
| 47 | ACVR1B | 1.13392277 |
| 48 | DDR2 | 1.12667179 |
| 49 | NME2 | 1.07859238 |
| 50 | EPHA2 | 1.05720278 |
| 51 | PDGFRB | 1.05402085 |
| 52 | TBK1 | 1.04515166 |
| 53 | STK24 | 1.04443599 |
| 54 | MET | 1.01468245 |
| 55 | DMPK | 0.99283692 |
| 56 | MAPKAPK3 | 0.97710465 |
| 57 | TAOK1 | 0.96193518 |
| 58 | TTN | 0.95216171 |
| 59 | JAK2 | 0.94638148 |
| 60 | MTOR | 0.92467489 |
| 61 | PBK | 0.92246266 |
| 62 | MAP3K1 | 0.91459949 |
| 63 | CHUK | 0.91194558 |
| 64 | PASK | 0.90669282 |
| 65 | MST1R | 0.89286909 |
| 66 | ARAF | 0.88886652 |
| 67 | FER | 0.88097344 |
| 68 | INSRR | 0.87009210 |
| 69 | MST4 | 0.86529138 |
| 70 | BMX | 0.85133910 |
| 71 | MELK | 0.85009540 |
| 72 | TYK2 | 0.84619953 |
| 73 | BRD4 | 0.84262929 |
| 74 | EIF2AK1 | 0.82312987 |
| 75 | TGFBR1 | 0.79079515 |
| 76 | TAOK2 | 0.76497655 |
| 77 | CDK8 | 0.76275147 |
| 78 | CDK9 | 0.76204290 |
| 79 | CDK7 | 0.75522458 |
| 80 | YES1 | 0.75196540 |
| 81 | MAP3K6 | 0.73638231 |
| 82 | DYRK1B | 0.71329344 |
| 83 | NUAK1 | 0.71019893 |
| 84 | CLK1 | 0.71012676 |
| 85 | TIE1 | 0.69349326 |
| 86 | TGFBR2 | 0.68063493 |
| 87 | ZAP70 | 0.67965033 |
| 88 | CAMK1D | 0.66867941 |
| 89 | GSK3A | 0.65859193 |
| 90 | PIM1 | 0.65068034 |
| 91 | TRPM7 | 0.64618495 |
| 92 | EIF2AK3 | 0.63638630 |
| 93 | MAP3K8 | 0.62861540 |
| 94 | MAP2K2 | 0.62328011 |
| 95 | PIK3CG | 0.62067348 |
| 96 | MAP3K9 | 0.61573360 |
| 97 | RPS6KB2 | 0.59866823 |
| 98 | MYLK | 0.58187049 |
| 99 | MAP3K5 | 0.55073937 |
| 100 | FGFR1 | 0.55044151 |
| 101 | ITK | 0.54450283 |
| 102 | SIK3 | 0.53567127 |
| 103 | MATK | 0.52327629 |
| 104 | RPS6KA2 | 0.51283170 |
| 105 | MAPK15 | 0.50886528 |
| 106 | PAK4 | 0.50608943 |
| 107 | BRSK2 | 0.49813966 |
| 108 | LMTK2 | 0.49745968 |
| 109 | AKT3 | 0.49534602 |
| 110 | MAP2K1 | 0.49062432 |
| 111 | RAF1 | 0.46616760 |
| 112 | MOS | 0.45704568 |
| 113 | WNK4 | 0.45538592 |
| 114 | IRAK4 | 0.45455503 |
| 115 | MARK2 | 0.45452462 |
| 116 | BMPR2 | 0.45077446 |
| 117 | KDR | 0.45035266 |
| 118 | FGFR2 | 0.44532045 |
| 119 | MAP3K14 | 0.44246073 |
| 120 | CDC42BPA | 0.44052714 |
| 121 | PRKAA1 | 0.43745828 |
| 122 | PRKG2 | 0.43393900 |
| 123 | CDK4 | 0.42710318 |
| 124 | NEK2 | 0.42519724 |
| 125 | MAPK7 | 0.42164570 |
| 126 | AKT2 | 0.42030933 |
| 127 | CSF1R | 0.42020752 |
| 128 | ILK | 0.41806494 |
| 129 | MAPK11 | 0.41515212 |
| 130 | ERBB2 | 0.38006633 |
| 131 | NTRK1 | 0.36181902 |
| 132 | IGF1R | 0.35433207 |
| 133 | IKBKE | 0.34865611 |
| 134 | PDPK1 | 0.34162414 |
| 135 | PAK2 | 0.34077535 |
| 136 | PRKCH | 0.33369610 |
| 137 | ABL1 | 0.32922061 |
| 138 | EGFR | 0.32303909 |
| 139 | BCKDK | 0.31984116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.37002998 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.98875280 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.33167618 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.32566287 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.16003293 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72227861 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69244512 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56595573 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56454625 |
| 10 | Insulin resistance_Homo sapiens_hsa04931 | 1.55865048 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.55665785 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.54863274 |
| 13 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.48847265 |
| 14 | Adherens junction_Homo sapiens_hsa04520 | 1.45205643 |
| 15 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.41967094 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 1.40973055 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38736358 |
| 18 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.37398980 |
| 19 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.35926741 |
| 20 | Bladder cancer_Homo sapiens_hsa05219 | 1.27599811 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23196303 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.19891993 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18886315 |
| 24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.18255048 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.17840041 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16343932 |
| 27 | Amoebiasis_Homo sapiens_hsa05146 | 1.15903354 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13264647 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12075256 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11355216 |
| 31 | Focal adhesion_Homo sapiens_hsa04510 | 1.11089894 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.10276740 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10131049 |
| 34 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.08429652 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.08402438 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08074788 |
| 37 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07322998 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.06621616 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06605814 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04968310 |
| 41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03051434 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.03034303 |
| 43 | Prostate cancer_Homo sapiens_hsa05215 | 1.02830180 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02404304 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97256699 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97228545 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.93500103 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89075623 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.88790764 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88221524 |
| 51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87622305 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87182435 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85543579 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84737226 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84520135 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84376776 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83713217 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83484067 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83346375 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82496791 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82005983 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80161322 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80040902 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79585737 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.79229065 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77868951 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77831648 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76534776 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75917471 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75724237 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74938194 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.74575281 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74270372 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.74231247 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71870691 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71149119 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70914960 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70545308 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70196976 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.69799287 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69663423 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69061717 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68819046 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68237999 |
| 85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68084218 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67700801 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67619753 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67505849 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67109247 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67017582 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66902548 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66507478 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.64584136 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64560215 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64224009 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63910615 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.63738852 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63317263 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63112027 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62984798 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62603000 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.61485295 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61161413 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.60930226 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60703698 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60407152 |
| 107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60386644 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59502219 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59436411 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59299108 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58320957 |
| 112 | Protein export_Homo sapiens_hsa03060 | 0.57868724 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57773682 |
| 114 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57410451 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57141116 |
| 116 | Measles_Homo sapiens_hsa05162 | 0.56992586 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56815124 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56297668 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.54073420 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.53855660 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53110509 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53010661 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52993537 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52465132 |
| 125 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52229419 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51612405 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50913472 |
| 128 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.49937338 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.49329499 |
| 130 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48924023 |
| 131 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47761420 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.47682508 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47596236 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47191723 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45882748 |
| 136 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45425827 |

